期刊文献+

血清胱抑素C在介入治疗糖尿病足中的意义 被引量:2

Cystatin C as a marker to evaluated the endovasclaur surgery for diabetic foot
下载PDF
导出
摘要 目的:探讨胱抑素C(Cys C)在糖尿病足发病及介入手术术后的意义。方法:选取2014年1月至2015年4月期间来我院就诊的糖尿病足患者40例(糖尿病足组),单纯糖尿病患者40例(单纯组),健康体检者40例(正常组);术前抽血检测患者血清胱抑素C(Cys C)、C-反应蛋白(C-RP)水平;糖尿病足组患者于术后第1、3、7天复查血清胱抑素C、C-反应蛋白水平及踝肱指数(ABI)。结果:术前正常组、单纯组与糖尿病足组血清Cys C和C-RP平均水平存在差异,差异有统计学意义(P <0. 05)。32例糖尿病足患者成功开通闭塞血管。糖尿病足组患者术后第1、3、7天血清Cys C、C-RP水平均呈先升高后降低趋势,各时间点两者水平均存在差异,差异有统计学意义(P <0. 008 3)。术后随访24月中,前12个月再次返院治疗者13例,后12个月再次返院治疗者16例;回顾性分析两组患者术前Cys C水平,前者较后平均水平要高,差异有统计学意义(P <0. 05)。结论:血清胱抑素C可能是糖尿病足的一项独立危险因素与预后的一项指标,可以作为糖尿病足介入手术疗效的评价指标。 Objective:To explore the role of cystatin C(CysC)in the physiopathology and prognostic after endovascualr operation in diabetic foot.Methods:120 patients including the outpatients and hospitalized between January 1st 2014 and April 30th 2015 were divided into three groups:patients with diabetic foot(diabetic group),patients with diabetes only(single group),physical examination(normal group),and 40 cases in each group respectively.All patients were to test the ankle brachial index(ABI),the value of serum CysC,Creactive protein(CRP)before endovascular surgery.The serum value of CysC and CRP on postoperative 1 d,3 d and 7 d were tested in diabetic foot group,and the ABI reexamination at the time of hospital discharge.Results:The value of the serum CysC,CRP and ABI at preoperative have a statistically difference(P<0.05)among the three groups,and the diabetic foot group highest of CysC,CRP and lowest of ABI.Thirty two patients were treated with endovascular successfully.To compare with preoperative score,values of CysC,CRP on postoperative 1d,3d are higher(P<0.008 3)and lower of 7d(P<0.008 3),and ABI higher(P<0.0083).32 patients were fellowed up for 24 months.Thirteen patients(within 1~12 months)and sixteen patients(within 12~24 months)relapsed and were back to hospital.Retrospective analysis the value of serum CysC of the two groups patients,there was a statistical difference(P<0.05).Conclusion:CysC may be an independent risk factor for diabetic foot and a prognostic marker of diabetic foot,it could also be a factor for evaluating the effective of endovascluar surgery.
作者 刘凤恩 刘建平 肖骏琦 段青 徐贤赟 唐金红 叶荣 乐志标 方萃福 张人波 LIU Fen-gen;LIU Jian-ping;XIAO Jun-qi;DUAN Qin;XU Xian-yun;TANG Jin-hong;YE Rong;LE Zhi-biao;FANG Cui-fu;ZHANG Ren-bo(The First Affiliated Hospital of Gannan Medical University,Ganzhou,Jiangxi 341000)
出处 《赣南医学院学报》 2018年第9期882-885,共4页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 2013年赣南医学院重点课题(编号:2D201303)
关键词 胱抑素C 糖尿病足 介入治疗 serum cystatin C diabetic foot endovascular therapy
  • 相关文献

参考文献3

二级参考文献34

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1856
  • 2Kim K W,MacFall J R,Payne M E. Classification of whitematter lesions on magnetic resonance imaging in elderly per-sons [J]. Biol Psychiatry, 2008,64(4) : 273 -280. DOI:10. 1016/j. biopsych. 2008. 03. 024.
  • 3Pantoni L. Cerebral small vessel disease: from pathogenesisand clinical characteristics to therapeutic challenges [ J ]. Lan-cet Neurol, 2010, 9(7) : 689 -701. DOI: 10. 1016/S1474-4422(10)70104-6.
  • 4Black S,Gao F,Bilbao J. Understanding white matter dis-ease: Imaging-pathological correlations in vascular cognitiveimpairment [ J]. Stroke, 2009,40(3 Suppl) : S48 — S52.DOI: 10.1161/STROKEAHA. 108.537704.
  • 5Tan G D, Lewis A V,James T J, ef al. Clinical usefulness ofcystatin C for the estimation of glomerular filtration rate intype 1 diabetes : reproducibility and accuracy compared withstandard measures and iohexol clearance[ J] . Diabetes care,2002,25(11) : 2004 - 2009. DOI: 10. 2337/diacare. 25.11.2004.
  • 6Dhamidharka V R,Kwon C,Stevens G. Serum cystatin C issuperior to serum creatinine as a marker of kidney function : ameta-analysis[ J]. Am J Kidney Dis, 2002,40(2) : 221 -226. DOI: 10, 1053/ajkd. 2002.34487.
  • 7Shlipak M G,Katz R,Samak M J, ei al. Cystatin C andprognosis for cardiovascular and kidney outcomes in elderlypersons without chronic kidney disease [ J ]. Ann Intern Med,2006,145(4) : 237 - 246. DOI: 10.7326/00034819-145-4-200608150-00003.
  • 8Stevens L A, Coresh J, Greene T, et al. Assessing kidneyfunction—measured and estimated glomerular filtration rate[J]. N Engl J Med, 2006, 354(23) : 2473-2483. DOI: 10.1056/NEJMra054415.
  • 9Shlipak M G, Samak M J, Katz R,et al. Cystatin C and therisk of death and cardiovascular events among elderly persons[J]. N Engl J Med, 2005, 352(20) : 2049-2060. DOI: 10.1056/NEJMoa043161.
  • 10Seliger S L, Longstreth W T Jr, Katz R, et al. Cystatin Cand subclinical brain infarction [ J ]. J Am Soc Nephrol,2005,16 ( 12 ): 3721-3727. DOI: 10. 1681/ASN.2005010006.

共引文献344

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部